{
    "id": 27606,
    "fullName": "CALR K385fs",
    "impact": "frameshift",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CALR K385fs (reported as K385fs*47) results in a change in the amino acid sequence of the Calr protein beginning at aa 385 of 417, likely resulting in premature truncation of the functional protein (UniProt.org). K385fs confers a gain of function to Calr, as indicated by activation of JAK-STAT signaling and is transforming in cell culture (PMID: 26817954, PMID: 26987905, PMID: 26668133).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11173,
                    "pubMedId": 26668133,
                    "title": "Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26668133"
                },
                {
                    "id": 11172,
                    "pubMedId": 26817954,
                    "title": "Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26817954"
                },
                {
                    "id": 11171,
                    "pubMedId": 26987905,
                    "title": "Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26987905"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 811,
        "geneSymbol": "CALR",
        "terms": [
            "CALR",
            "cC1qR",
            "CRT",
            "HEL-S-99n",
            "RO",
            "SSA"
        ]
    },
    "variant": "K385fs",
    "createDate": "04/06/2018",
    "updateDate": "08/21/2018",
    "referenceTranscriptCoordinates": {
        "id": 90935,
        "transcript": "NM_004343",
        "gDna": "chr19:g.(12943811_12943812)",
        "cDna": "c.(1153_1152)",
        "protein": "p.K385fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13583,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Jakafi (ruxolitinib) inhibited growth of transformed cells expressing CALR L385fs in culture (PMID: 26668133).",
            "molecularProfile": {
                "id": 29154,
                "profileName": "CALR K385fs"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11173,
                    "pubMedId": 26668133,
                    "title": "Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26668133"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29154,
            "profileName": "CALR K385fs",
            "profileTreatmentApproaches": [
                {
                    "id": 17581,
                    "name": "JAK2 Inhibitor - ATP competitive",
                    "profileName": "CALR K385fs"
                },
                {
                    "id": 17580,
                    "name": "JAK Inhibitor (Pan) - ATP competitive",
                    "profileName": "CALR K385fs"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 90935,
            "transcript": "NM_004343",
            "gDna": "chr19:g.(12943811_12943812)",
            "cDna": "c.(1153_1152)",
            "protein": "p.K385fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}